GENANI Trademark

Trademark Overview


On Thursday, April 30, 2020, a trademark application was filed for GENANI with the United States Patent and Trademark Office. The USPTO has given the GENANI trademark a serial number of 88894993. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, June 17, 2024. This trademark is owned by GENANI CORPORATION. The GENANI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations for repair of organs damaged by trauma, drugs, radiation, hypoxia, or explosive device; pharmaceuticals and pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in skin care; astringents; pharmaceutical skin lotions; stem cells for medical purposes; pharmaceutical products and preparations, namely, medications for the treatment of dermatological conditions
genani

General Information


Serial Number88894993
Word MarkGENANI
Filing DateThursday, April 30, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Description of MarkThe mark consists of the word "GENANI" in stylized font inside a horizontal oval egg design with the left side of the oval consisting of a DNA helix design.
Goods and ServicesPharmaceuticals and pharmaceutical preparations for repair of organs damaged by trauma, drugs, radiation, hypoxia, or explosive device; pharmaceuticals and pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in skin care; astringents; pharmaceutical skin lotions; stem cells for medical purposes; pharmaceutical products and preparations, namely, medications for the treatment of dermatological conditions
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGENANI CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60611

Party NameGENANI CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60611

Trademark Events


Event DateEvent Description
Monday, August 3, 2020NON-FINAL ACTION E-MAILED
Monday, May 4, 2020NEW APPLICATION ENTERED
Tuesday, May 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 13, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 27, 2020ASSIGNED TO EXAMINER
Monday, August 3, 2020NON-FINAL ACTION WRITTEN
Monday, August 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 22, 2021SUSPENSION LETTER WRITTEN
Monday, February 22, 2021LETTER OF SUSPENSION E-MAILED
Monday, February 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 20, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 28, 2022ASSIGNED TO EXAMINER
Tuesday, March 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 9, 2022SOU EXTENSION 1 FILED
Friday, June 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 9, 2022SOU EXTENSION 1 GRANTED
Thursday, August 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 23, 2022ASSIGNED TO EXAMINER
Friday, June 16, 2023SOU EXTENSION 2 FILED
Friday, June 16, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 3 FILED
Monday, December 18, 2023SOU EXTENSION 3 GRANTED
Monday, June 17, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024SOU EXTENSION 4 FILED
Monday, June 17, 2024SOU EXTENSION 4 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED